Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
NN Inc
NNBR
$298M
| $558K | ﹤0.01% |
220,728
-205,772
| -48% | -$570K |
|
3102
Twin Disc
TWIN
$349M
| $558K | ﹤0.01% |
61,593
-200
| -0.3% | -$2.45K |
|
3103
Voyager Therapeutics
VYGR
$198M
| $557K | ﹤0.01% |
+94,300
| New | +$637K |
|
|
TPTX
3104
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $557K | ﹤0.01% |
7,400
-11,300
| -60% | -$502K |
|
|
AC
3105
DELISTED
Associated Capital Group
AC
| $555K | ﹤0.01% |
15,500
-12,000
| -44% | -$460K |
|
|
PRTY
3106
DELISTED
Party City Holdco Inc.
PRTY
| $555K | ﹤0.01% |
+420,347
| New | +$930K |
|
|
ZOM
3107
DELISTED
Zomedica Corp.
ZOM
| $552K | ﹤0.01% |
+2,507,500
| New | +$638K |
|
|
BSJO
3108
DELISTED
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
| $551K | ﹤0.01% |
25,300
+11,043
| +77% | +$252K |
|
|
ZY
3109
DELISTED
Zymergen Inc. Common Stock
ZY
| $550K | ﹤0.01% |
447,167
+54,600
| +14% | +$91.5K |
|
3110
Amneal Pharmaceuticals
AMRX
$6.02B
| $548K | ﹤0.01% |
172,400
+103,800
| +151% | +$376K |
|
3111
Heritage Financial
HFWA
$1.23B
| $548K | ﹤0.01% |
21,789
-10,900
| -33% | -$272K |
|
|
IAUX
3112
i-80 Gold Corp
IAUX
$1.43B
| $548K | ﹤0.01% |
+304,200
| New | +$718K |
|
3113
Laureate Education
LAUR
$5.15B
| $548K | ﹤0.01% |
47,400
-1,191,300
| -96% | -$14.1M |
|
3114
AvalonBay Communities
AVB
$26.3B
| $547K | ﹤0.01% |
+2,814
| New | +$609K |
|
3115
HireQuest
HQI
$246M
| $547K | ﹤0.01% |
38,800
+28,100
| +263% | +$441K |
|
|
MPX
3116
DELISTED
Marine Products Corp
MPX
| $544K | ﹤0.01% |
57,202
-600
| -1% | -$6.63K |
|
3117
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.35B
| $544K | ﹤0.01% |
6,400
-1,000
| -14% | -$91.4K |
|
3118
InnovAge Holding
INNV
$1.45B
| $542K | ﹤0.01% |
123,800
+45,600
| +58% | +$238K |
|
|
HLTH
3119
DELISTED
Cue Health Inc. Common Stock
HLTH
| $542K | ﹤0.01% |
+169,282
| New | +$917K |
|
3120
iShares Agency Bond ETF
AGZ
$566M
| $541K | ﹤0.01% |
+4,917
| New | +$542K |
|
3121
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$273M
| $541K | ﹤0.01% |
12,100
+7,400
| +157% | +$370K |
|
|
UBX
3122
DELISTED
Unity Biotechnology
UBX
| $540K | ﹤0.01% |
95,772
+5,100
| +6% | +$42.5K |
|
3123
Five Point Holdings
FPH
$372M
| $537K | ﹤0.01% |
137,402
-78,801
| -36% | -$407K |
|
|
NAAS
3124
NaaS Technology Inc
NAAS
$58.7M
| $537K | ﹤0.01% |
281
+233
| +485% | +$1.86M |
|
3125
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.92B
| $537K | ﹤0.01% |
17,500
+5,000
| +40% | +$166K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.